Abstract
Purpose
Advanced colon cancers with bladder invasion pose a heavy burden and challenge towards patients and surgeons. Herein, we report our series with regards to operative and oncological outcomes in our 8 years of experience.
Methods
All patients with advanced colonic tumours and suspected bladder invasion being operated from 2012 to 2020 were included. The histological findings, clinical and oncological outcomes were evaluated.
Results
Twenty-two patients were included. Partial cystectomy was performed in 17 of them (77%). No neoadjuvant treatment was prescribed. All preoperative computed tomography (CT) scan showed bladder invasion or colovesical fistula. True tumour invasion to bladder (T4b disease) was confirmed in 17 patients (77%) by histopathology. The 3-year overall survival and recurrence rates were 82% and 9%, respectively.
Conclusion
En bloc resection of colonic tumour with adherent bladder in advanced colon cancers can achieve a good operative and oncological outcome without neoadjuvant therapy. The relatively low concordance rate between preoperative CT scan and final histopathology may limit the benefit of routine administration of neoadjuvant therapy as it may overtreat and delay subsequent oncological treatment of our patients with possible added morbidity.
Similar content being viewed by others
References
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–53.
Vuillermet C, Meillat H, Manceau G, Creavin B, Eveno C, Benoist S, Parc Y, LefevreFRENCH research group, JH. Advanced colonic cancer with clinically suspected bladder invasion: outcomes and prognosis from a multicentric study of 117 patients from the FRENCH research group. Surgery. 2020;168:786–92.
Klaver CE, Gietelink L, Bemelman WA, Wouters MW, Wiggers T, Tollenaar RA, Tanis PJ; Dutch Surgical Colorectal Audit Group. Locally advanced colon cancer: evaluation of current clinical practice and treatment outcomes at the population level J Natl Compr Canc Netw. 2017;15:181-190.
Kobayashi T, Kamoto T, Sugino Y, Takeuchi H, Habuchi T, Ogawa O. High incidence of urinary bladder involvement in carcinoma of the sigmoid and rectum: a retrospective review of 580 patients with colorectal carcinoma. J Surg Oncol. 2003;84:209–14.
Carne PW, Frye JN, Kennedy-Smith A, Keating J, Merrie A, Dennett E, Frizelle FA. Local invasion of the bladder with colorectal cancers: surgical management and patterns of local recurrence. Dis Colon Rectum. 2004;47:44–7.
Luo HL, Tsai KL, Lin SE, Chiang PH. Outcome of urinary bladder recurrence after partial cystectomy for en bloc urinary bladder adherent colorectal cancer resection. Int J Colorectal Dis. 2013;28:631–5.
Gao F, Cao YF, Chen LS, Zhang S, Tang ZJ, Liang JL. Outcome of surgical management of the bladder in advanced colorectal cancer. Int J Colorectal Dis. 2007;22:21–4.
Talamonti MS, Shumate CR, Carlson GW, Curley SA. Locally advanced carcinoma of the colon and rectum involving the urinary bladder. Surg Gynecol Obstet. 1993;177:481–7.
Yoshida T, Shida D, Taniguchi H, Tsukamoto S, Kanemitsu Y. Long-term outcomes following partial versus complete cystectomy in advanced colorectal cancer with regarding to the extent of bladder invasion. Ann Surg Oncol. 2019;26:1569–76.
Li JC, Chong CC, Ng SS, Yiu RY, Lee JF, Leung KL. En bloc urinary bladder resection for locally advanced colorectal cancer: a 17-year experience. Int J Colorectal Dis. 2011;26:1169–76.
Winter DC, Walsh R, Lee G, Kiely D, O’Riordain MG, O’Sullivan GC. Local involvement of the urinary bladder in primary colorectal cancer: outcome with en bloc resection. Ann Surg Oncol. 2007;14:441–6.
Mohan HM, Evans MD, Larkin JO, Beynon J, Winter DC. Multivisceral resection in colorectal cancer: a systemic review. Ann Surg Oncol. 2013;20:2929–36.
Hunter JA, Ryan JA Jr, Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg. 1987;154:67–71.
Devine RM, Dozois RR. Surgical management of local advanced adenocarcinoma of the rectum. World J Surg. 1992;16:486–9.
Foxtrot Collaboration Group Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial Lancet Oncol. 2012;13:1152-1160.
Arredondo J, Pastor E, Simó V, Beltrán M, Castañón C, Magdaleno MC, Matanza I, Notarnicola M, Ielpo B. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review. Tech Coloproctol. 2020;24:1001–15.
Dehal A, Graff-Baker AN, Vuong B, Fischer T, Klempner SJ, Chang SC, Grunkemeier GL, Bilchik AJ, Goldfarb M. Neoadjuvant chemotherapy improves survival in patients with clinical T4b colon cancer. J Gastrointest Surg. 2018;22:242–9.
Hawkins AT, Ford MM, Geiger TM, Hopkins MB, Kachnic LA, Muldoon RL, Glasgow SC. Neoadjuvant radiation for clinical T4 colon cancer: a potential improvement to overall survival. Surgery. 2019;165:469–75.
Takenami T, Tsujinaka S, Takahashi J, Tamaki S, Maemoto R, Fukuda R, Ishikawa H, Kakizawa N, Hasegawa F, Kikugawa R, Miyakura Y, Suzuki K, Tanaka A, Rikiyama T. Efficacy of neoadjuvant chemotherapy with capecitabine plus oxaliplatin in the treatment of locally advanced sigmoid colon cancer invading the urinary bladder: a report of three cases. Case Rep Surg. 2019;2019:8129358.
de Gooyer JM, Verstegen’t Lam-Boer J, Radema SA, Verhoeven RHA, Verhoef C, Schreinemakers JMJ, de Wilt JHW, MG. Neoadjuvant chemotherapy for locally advanced T4 colon cancer: a nationwide propensity-score matched cohort analysis. Dig Surg. 2020;37:292–301.
Huang CM, Huang MY, Ma CJ, Yeh YS, Tsai HL, Huang CW, Huang CJ, Wang JY. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer. Radiat Oncol. 2017;12:48.
Krishnamurty DM, Hawkins AT, Wells KO, Mutch MG, Silviera ML, Glasgow SC, Hunt SR, Dharmarajan S. Neoadjuvant radiation therapy in locally advanced colon cancer: a cohort analysis. J Gastrointest Surg. 2018;22:906–12.
Kondo A, Sasaki T, Kitaguchi D, Tsukada Y, Nishizawa Y, Ito M. Resection of the urinary bladder for locally advanced colorectal cancer: a retrospective comparison of partial versus total cystectomy. BMC Surg. 2019;19:63.
National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology (NCCN guidelines®), colon cancer. Version 4.2020. https://www.nccn.org/professionals/physician_gls. Assessed 16 July 2020.
Seymour MT, Morton D, and on behalf of the International FOxTROT trial investigators (2019) FOxTROT: an international randomised controlled trial in 1052 patients (pts) evaluating neoadjuvant chemotherapy (NAC) for colon cancer. J Clin Oncol 37 suppl, 3504.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tsang, Y., Lau, C. Outcomes of Partial or Total Cystectomy in Advanced Colon Cancer with Suspected Bladder Invasion—Our 8-Year Experience and Literature Review. J Gastrointest Canc 53, 394–402 (2022). https://doi.org/10.1007/s12029-021-00623-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-021-00623-z